Wegovy Stories Before and After: Reading the Results Honestly

Why individual stories don't settle the question of what you might expect

It's completely understandable to search for Wegovy stories before and after when you're trying to decide whether this medicine is worth pursuing. A number on a page means less to most people than seeing what changed for someone else. The problem is survivorship: the people who post results tend to be the people for whom results were dramatic. The person who lost 6% and stopped due to side effects rarely makes a video about it.

Trial data exists precisely to correct for this. STEP 1 randomised 1,961 adults without diabetes; roughly two-thirds were assigned semaglutide 2.4mg and the rest a placebo, both groups alongside lifestyle support. Average weight loss in the semaglutide group was around 14.9% of body weight by week 68. Around a third of participants lost 20% or more. Roughly one in seven lost less than 5%. That spread is what a realistic picture looks like, some people lose considerably more than the average, others less.

What the stories almost never mention is the dose journey. Treatment starts at 0.25mg and the prescriber titrates upward roughly every four weeks. The early weeks are largely about your body adjusting, not about dramatic change. Understanding that timeline is part of deciding whether Wegovy fits your life right now.

The newer 7.2mg dose changes the ceiling, but not the individual picture

Most before-and-after accounts online predate the MHRA's approval of a higher maintenance dose. In January 2026 the MHRA approved 7.2mg as a licensed maintenance dose for semaglutide (Wegovy), initially delivered as three 2.4mg pens weekly. A dedicated single-dose 7.2mg pen followed in April 2026, licensed for adults with a BMI of 30 or above.

Trials at 7.2mg reported average weight loss of around 20.7% over 72 weeks, approaching the results seen in tirzepatide trials. For anyone whose before-and-after research is based on older material, that's a meaningful update. It doesn't change the fact that individual variation persists, or that a prescriber still needs to assess whether that dose is appropriate for you.

If you're weighing up which medicine and which route makes sense, our look at Wegovy results before and after sets the trial evidence alongside the practical experience of treatment. For questions about how long it takes to see changes, the timeline of how Wegovy works is a useful read before committing to anything.

What actually shapes how much weight someone loses on Wegovy

The before-and-after framing implies that the medicine is the only variable. It isn't. NHS guidance on semaglutide is clear that Wegovy is intended alongside a reduced-calorie diet and increased physical activity, not instead of those things. The clinical trials were run with structured lifestyle support. Results in everyday clinical practice can differ.

Individual factors that matter include starting weight (percentage loss tends to look larger when starting weight is higher), metabolic health, how well the GI side effects are managed during dose escalation, how consistently the injection is taken each week, and whether dose increases happen at the right pace. Gastrointestinal symptoms (nausea, constipation, bloating and others) are common in the early weeks and can be discouraging. Most settle. For some people, the highest dose isn't tolerable and they remain on a lower one.

The Wegovy success stories before and after that resonate most tend to come from people with good clinical support throughout. That's not incidental. A prescriber who reviews your progress, adjusts your dose appropriately and is available when you have questions makes a practical difference to how the medicine works for you. Our detailed overview of Wegovy before and after outcomes goes into these factors further, and our clinical team is structured around exactly that kind of ongoing support.

How to read a before-and-after story without being misled by it

Before-and-after accounts are human and often genuine. A few things to check before you let them set your expectations: how long was the treatment period? Six months looks very different to 18. What dose did the person reach? Someone on 2.4mg for six months and someone on 7.2mg for 18 months are not comparable. Was there a significant change in eating or exercise alongside? Most people who do well credit both. And was the account from a clinically supervised source, or from someone self-administering medicine bought without proper assessment?

That last point matters beyond results. Fake Wegovy pens have been seized in the UK in significant quantities, some containing insulin rather than semaglutide. The MHRA has been explicit about the risks of buying injectable weight-loss medicines from unverified sellers. A genuine Wegovy weight loss before and after story starts with a genuine prescription from a genuine pharmacy, one you can check on the GPhC register.

If you're at the point of deciding whether to go ahead, the guide to buying Wegovy safely in the UK explains what a legitimate supply route looks like. And our free consultation is reviewed the same day by a GPhC-registered prescriber, a real clinician who reads your answers and assesses whether this medicine is right for you specifically.